USX:GRCL - Gracell Biotechnologies Inc Gracell Biotechnologies Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 13.22    -1.620 (-10.92%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

16 Sep 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Wei Cao

IPO: 2021-01-08

Headquarters: US

Employees: 202

Homepage

Description

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer.